Almeida FR, Dal-Fabbro C, Chaves Jr CM Síndrome da apneia e hipopneia obstrutiva do sono (SAHOS): tratamento com aparelhos intra-orais. In: Tufik, S. Medicina e biologia do sono.1ª ed. São Paulo: Manole; 2008. p. 263-80.
Battan G, Kumar S, Panwar A, Atam V, Kumar P, Gangwar A, Roy U Effect of CPAP Therapy in Improving Daytime Sleepiness in Indian Patients with Moderate and Severe OSA. J Clin Diagn Res. 2016 Nov;10(11):OC14-OC16. doi: 10.7860/JCDR/2016/23800.8876. Epub 2016 Nov 1.
Correa CM, Gismondi RA, Cunha AR, Neves MF, Oigman W Twenty-four hour Blood Pressure in Obese Patients with Moderate-to-Severe Obstructive Sleep Apnea. Arq Bras Cardiol. 2017 Oct;109(4):313-320. doi: 10.5935/abc.20170130. Epub 2017 Sep 4. Portuguese, English.
Flegal KM, Kit BK, Orpana H, Graubard BI Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013 Jan 2;309(1):71-82. doi: 10.1001/jama.2012.113905. Review.
Gottlieb DJ, Ellenbogen JM, Bianchi MT, Czeisler CA Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study. BMC Med. 2018 Mar 20;16(1):44. doi: 10.1186/s12916-018-1025-7.
Guglielmi O, Jurado-Gámez B, Gude F, Buela-Casal G Occupational health of patients with obstructive sleep apnea syndrome: a systematic review. Sleep Breath. 2015 Mar;19(1):35-44. doi: 10.1007/s11325-014-1015-8. Epub 2014 Jun 22. Review.
Hamilton GS, Meredith IT, Walker AM, Solin P Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans. Sleep. 2009 Feb;32(2):263-70.
Hoffstein V Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath. 2007 Mar;11(1):1-22. Review.
Jurado-Gámez B, Guglielmi O, Gude F, Buela-Casal G Workplace accidents, absenteeism and productivity in patients with sleep apnea. Arch Bronconeumol. 2015 May;51(5):213-8. doi: 10.1016/j.arbres.2014.07.003. Epub 2014 Aug 13. English, Spanish.
Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003 Jul;52(7):1779-85.
Kuhn E, Schwarz EI, Bratton DJ, Rossi VA, Kohler M Effects of CPAP and Mandibular Advancement Devices on Health-Related Quality of Life in OSA: A Systematic Review and Meta-analysis. Chest. 2017 Apr;151(4):786-794. doi: 10.1016/j.chest.2017.01.020. Epub 2017 Jan 24. Review.
Lee B, Shao J Adiponectin and energy homeostasis. Rev Endocr Metab Disord. 2014 Jun;15(2):149-56. doi: 10.1007/s11154-013-9283-3. Review.
Lopez PP, Stefan B, Schulman CI, Byers PM Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg. 2008 Sep;74(9):834-8.
Ogden CL, Carroll MD, Kit BK, Flegal KM Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014 Feb 26;311(8):806-14. doi: 10.1001/jama.2014.732.
Ohashi K, Ouchi N, Matsuzawa Y Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012 Oct;94(10):2137-42. doi: 10.1016/j.biochi.2012.06.008. Epub 2012 Jun 17. Review.
Schwartz M, Acosta L, Hung YL, Padilla M, Enciso R Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath. 2017 Nov 11. doi: 10.1007/s11325-017-1590-6. [Epub ahead of print] Review.
Shelgikar AV, Aronovich S, Stanley JJ Multidisciplinary Alternatives to CPAP Program for CPAP-Intolerant Patients. J Clin Sleep Med. 2017 Mar 15;13(3):505-510. doi: 10.5664/jcsm.6508. Review.
Spicuzza L, Caruso D, Di Maria G Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis. 2015 Sep;6(5):273-85. doi: 10.1177/2040622315590318. Review.
Taheri S, Lin L, Austin D, Young T, Mignot E Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004 Dec;1(3):e62. Epub 2004 Dec 7.
Takama N, Kurabayashi M Influence of untreated sleep-disordered breathing on the long-term prognosis of patients with cardiovascular disease. Am J Cardiol. 2009 Mar 1;103(5):730-4. doi: 10.1016/j.amjcard.2008.10.035. Epub 2009 Jan 12.
Tefft BC Prevalence of motor vehicle crashes involving drowsy drivers, United States, 1999-2008. Accid Anal Prev. 2012 Mar;45:180-6. doi: 10.1016/j.aap.2011.05.028.
Wozniak DR, Lasserson TJ, Smith I Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2014 Jan 8;(1):CD007736. doi: 10.1002/14651858.CD007736.pub2. Review.
Yaggi HK, Araujo AB, McKinlay JB Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006 Mar;29(3):657-61.
Young D, Collop N Advances in the treatment of obstructive sleep apnea. Curr Treat Options Neurol. 2014 Aug;16(8):305. doi: 10.1007/s11940-014-0305-6.
Efficiency of Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese Class III
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.